2016年EASL临床实践指南:胆结石的预防,诊断和治疗

2016-04-11 欧洲肝脏研究学会 J Hepatol, 2016

发布日期:2016-04-11 英文标题:EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones  制定者:欧洲肝病学会(EASL) 出处:J Hepatol, 2016  内容介绍: 2016年4月,欧洲肝脏研究学会(EASL)发布了胆结石的预防,诊断和治疗指南

中文标题:

2016年EASL临床实践指南:胆结石的预防,诊断和治疗

英文标题:

EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones

发布机构:

欧洲肝脏研究学会

发布日期:

2016-04-11

简要介绍:

发布日期:2016-04-11
英文标题:EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones 
制定者:欧洲肝病学会(EASL)
出处:J Hepatol, 2016 
内容介绍:
2016年4月,欧洲肝脏研究学会(EASL)发布了胆结石的预防,诊断和治疗指南,旨在为胆结石的余地,诊断和治疗提供最新建议,指南涉及的主要内容如下:胆结石的预防;胆囊结石的诊断;胆囊结石的药物治疗,胆囊结石的外科手术治疗;胆管结石的诊断;胆管结石的内镜和手术治疗;肝内胆管结石的治疗;妊娠期胆结石的治疗。


相关资料下载:
[AttachmentFileName(sort=100, fileName=2016年EASL临床实践指南:胆结石的预防,诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=06ae51c001203678, title=2016年EASL临床实践指南:胆结石的预防,诊断和治疗, enTitle=EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones, guiderFrom=J Hepatol, 2016, authorId=null, author=, summary=发布日期:2016-04-11 英文标题:EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones  制定者:欧洲肝病学会(EASL) 出处:J Hepatol, 2016  内容介绍: 2016年4月,欧洲肝脏研究学会(EASL)发布了胆结石的预防,诊断和治疗指南, cover=, journalId=null, articlesId=null, associationId=84, associationName=欧洲肝脏研究学会, associationIntro=欧洲肝脏研究学会(European Association for the Study of the Liver,EASL),是目前在欧洲居于首要地位的肝病学会,其发布的指南包括各种肝病的处理,同时对诊断、治疗和预防方法进行规范化定义。该协会下属的指南组按疾病划分为肝细胞癌、乙肝、丙肝、酒精性肝病、急性肝衰竭和威尔逊氏病等。其协会官方期刊《Journal of Hepatology》为月刊。, copyright=0, guiderPublishedTime=Mon Apr 11 08:00:00 CST 2016, originalUrl=, linkOutUrl=, content=发布日期:2016-04-11<br> 英文标题:EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones <br> 制定者:欧洲肝病学会(EASL)<br> 出处:J Hepatol, 2016 <br> 内容介绍:<br> 2016年4月,欧洲肝脏研究学会(EASL)发布了胆结石的预防,诊断和治疗指南,旨在为胆结石的余地,诊断和治疗提供最新建议,指南涉及的主要内容如下:胆结石的预防;胆囊结石的诊断;胆囊结石的药物治疗,胆囊结石的外科手术治疗;胆管结石的诊断;胆管结石的内镜和手术治疗;肝内胆管结石的治疗;妊娠期胆结石的治疗。<br><div><br></div>, tagList=[TagDto(tagId=327, tagName=EASL), TagDto(tagId=7195, tagName=胆结石)], categoryList=[CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=null, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2786, appHits=179, showAppHits=0, pcHits=1840, showPcHits=1115, likes=189, shares=2, comments=4, approvalStatus=1, publishedTime=Mon Apr 11 00:00:00 CST 2016, publishedTimeString=2016-04-11, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Mon Apr 11 00:00:00 CST 2016, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 13:53:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016年EASL临床实践指南:胆结石的预防,诊断和治疗)])
2016年EASL临床实践指南:胆结石的预防,诊断和治疗
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=925266, encodeId=ee7492526612, content=谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07df5460845, createdName=ms9000000483993309, createdTime=Thu Feb 18 13:50:29 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886975, encodeId=852d8869e5fe, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI1XVbYiaTDlaJvTVTpCVM9Rx5NVQuCtcR2DyhYO0kDC7s6ZIr7q7ug86dMGPEdf8TxKAZYXwqiaFyw/132, createdBy=94695259847, createdName=echo2601, createdTime=Mon Sep 21 00:04:14 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366282, encodeId=f09f366282e8, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/08/57d0303a43f58d1cee78b44b16a071d0.jpg, createdBy=2b115092569, createdName=145d7a23m23暂无昵称, createdTime=Thu May 16 06:52:44 CST 2019, time=2019-05-16, status=1, ipAttribution=)]
    2021-02-18 ms9000000483993309

    谢谢!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=925266, encodeId=ee7492526612, content=谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07df5460845, createdName=ms9000000483993309, createdTime=Thu Feb 18 13:50:29 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886975, encodeId=852d8869e5fe, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI1XVbYiaTDlaJvTVTpCVM9Rx5NVQuCtcR2DyhYO0kDC7s6ZIr7q7ug86dMGPEdf8TxKAZYXwqiaFyw/132, createdBy=94695259847, createdName=echo2601, createdTime=Mon Sep 21 00:04:14 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366282, encodeId=f09f366282e8, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/08/57d0303a43f58d1cee78b44b16a071d0.jpg, createdBy=2b115092569, createdName=145d7a23m23暂无昵称, createdTime=Thu May 16 06:52:44 CST 2019, time=2019-05-16, status=1, ipAttribution=)]
    2020-09-21 echo2601

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=925266, encodeId=ee7492526612, content=谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07df5460845, createdName=ms9000000483993309, createdTime=Thu Feb 18 13:50:29 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886975, encodeId=852d8869e5fe, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI1XVbYiaTDlaJvTVTpCVM9Rx5NVQuCtcR2DyhYO0kDC7s6ZIr7q7ug86dMGPEdf8TxKAZYXwqiaFyw/132, createdBy=94695259847, createdName=echo2601, createdTime=Mon Sep 21 00:04:14 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366282, encodeId=f09f366282e8, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/08/57d0303a43f58d1cee78b44b16a071d0.jpg, createdBy=2b115092569, createdName=145d7a23m23暂无昵称, createdTime=Thu May 16 06:52:44 CST 2019, time=2019-05-16, status=1, ipAttribution=)]
    2019-05-16 145d7a23m23暂无昵称

    谢谢

    0